Old Web
English
Sign In
Acemap
>
Paper
>
Favorable Modulation of Chimeric Antigen Receptor T Cells Safety and Efficacy By the Non-Covalent BTK Inhibitor Vecabrutinib
Favorable Modulation of Chimeric Antigen Receptor T Cells Safety and Efficacy By the Non-Covalent BTK Inhibitor Vecabrutinib
2021
Mohamad M. Adada
Reona Sakemura
Michelle J. Cox
Caludia Manriquez-Roman
Elizabeth L. Siegler
Erin E. Tapper
Carli M. Stewart
Kendall J. Schick
Ismail Can
Ekene J. Ogbodo
Evandro D. Bezerra
Lionel A. Kankeu Fonkoua
Mehrdad Hefazi
Michael W. Ruff
Pietro Taverna
Judith A. Fox
Gloria Olivier
Susan L Slager
Wei Ding
Sameer A. Parikh
Neil E. Kay
Saad S. Kenderian
Keywords:
Chemistry
non covalent
Bruton's tyrosine kinase
Cell biology
Chimeric antigen receptor
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]